These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38497289)

  • 21. Discrepancy in p16 expression in patients with HPV-associated head and neck squamous cell carcinoma in Thailand: clinical characteristics and survival outcomes.
    Arsa L; Siripoon T; Trachu N; Foyhirun S; Pangpunyakulchai D; Sanpapant S; Jinawath N; Pattaranutaporn P; Jinawath A; Ngamphaiboon N
    BMC Cancer; 2021 May; 21(1):504. PubMed ID: 33957888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The applicability of new TNM classification for humanpapilloma virus-related oropharyngeal cancer in the 8th edition of the AJCC/UICC TNM staging system in Japan: A single-centre study.
    Sano D; Yabuki K; Arai Y; Tanabe T; Chiba Y; Nishimura G; Takahashi H; Yamanaka S; Oridate N
    Auris Nasus Larynx; 2018 Jun; 45(3):558-565. PubMed ID: 28760331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
    Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G
    Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk profiling based on p16 and HPV DNA more accurately predicts location of disease relapse in patients with oropharyngeal squamous cell carcinoma.
    Rasmussen JH; Grønhøj C; Håkansson K; Friborg J; Andersen E; Lelkaitis G; Klussmann JP; Wittekindt C; Wagner S; Vogelius IR; von Buchwald C
    Ann Oncol; 2019 Apr; 30(4):629-636. PubMed ID: 30657857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detailed Analysis of Clinicopathologic Factors Demonstrate Distinct Difference in Outcome and Prognostic Factors Between Surgically Treated HPV-Positive and Negative Oropharyngeal Cancer.
    Iyer NG; Dogan S; Palmer F; Rahmati R; Nixon IJ; Lee N; Patel SG; Shah JP; Ganly I
    Ann Surg Oncol; 2015 Dec; 22(13):4411-21. PubMed ID: 25801358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is There a Role for Sex Hormone Receptors in Head-and-neck Cancer? Links with HPV Infection and Prognosis.
    DE Oliveira Neto CP; Brito HO; DA Costa RMG; Brito LMO
    Anticancer Res; 2021 Aug; 41(8):3707-3716. PubMed ID: 34281829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiographic retropharyngeal lymph node involvement in HPV-associated oropharyngeal carcinoma: Patterns of involvement and impact on patient outcomes.
    Lin TA; Garden AS; Elhalawani H; Elgohari B; Jethanandani A; Ng SP; Mohamed AS; Frank SJ; Glisson BS; Debnam JM; Sturgis EM; Phan J; Reddy JP; Fuller CD; Morrison WH; Skinner HD; Rosenthal DI; Gunn GB
    Cancer; 2019 May; 125(9):1536-1546. PubMed ID: 30620385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double positivity for HPV-DNA/p16
    Mena M; Taberna M; Tous S; Marquez S; Clavero O; Quiros B; Lloveras B; Alejo M; Leon X; Quer M; Bagué S; Mesia R; Nogués J; Gomà M; Aguila A; Bonfill T; Blazquez C; Guix M; Hijano R; Torres M; Holzinger D; Pawlita M; Pavon MA; Bravo IG; de Sanjosé S; Bosch FX; Alemany L
    Oral Oncol; 2018 Mar; 78():137-144. PubMed ID: 29496041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human Papillomavirus-associated oropharyngeal cancer: an observational study of diagnosis, prevalence and prognosis in a UK population.
    Evans M; Newcombe R; Fiander A; Powell J; Rolles M; Thavaraj S; Robinson M; Powell N
    BMC Cancer; 2013 May; 13():220. PubMed ID: 23634887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing.
    Nauta IH; Rietbergen MM; van Bokhoven AAJD; Bloemena E; Lissenberg-Witte BI; Heideman DAM; Baatenburg de Jong RJ; Brakenhoff RH; Leemans CR
    Ann Oncol; 2018 May; 29(5):1273-1279. PubMed ID: 29438466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Malm IJ; Fan CJ; Yin LX; Li DX; Koch WM; Gourin CG; Pitman KT; Richmon JD; Westra WH; Kang H; Quon H; Eisele DW; Fakhry C
    Cancer; 2017 May; 123(10):1768-1777. PubMed ID: 28055120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Relationship between human papilloma virus infection and expression of p16 and EGFR in head and neck squamous cell carcinoma and their prognostic significance].
    Ma L; Wang D; Wufuer A; Wu R; Zhang S; Wang R
    Zhonghua Zhong Liu Za Zhi; 2014 Jan; 36(1):23-8. PubMed ID: 24685082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer.
    Lassen P; Primdahl H; Johansen J; Kristensen CA; Andersen E; Andersen LJ; Evensen JF; Eriksen JG; Overgaard J;
    Radiother Oncol; 2014 Dec; 113(3):310-6. PubMed ID: 25544647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of EGFR and HPV-associated p16 in oropharyngeal carcinoma: correlation and influence on prognosis after radiotherapy in the randomized DAHANCA 5 and 7 trials.
    Lassen P; Overgaard J; Eriksen JG
    Radiother Oncol; 2013 Sep; 108(3):489-94. PubMed ID: 24060179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic impact of human papillomavirus status, survivin, and epidermal growth factor receptor expression on survival in patients treated with radiochemotherapy for very advanced nonresectable oropharyngeal cancer.
    Semrau R; Duerbaum H; Temming S; Huebbers C; Stenner M; Drebber U; Klussmann JP; Müller RP; Preuss SF
    Head Neck; 2013 Sep; 35(9):1339-44. PubMed ID: 23042483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Use of HPV16-E5, EGFR, and pEGFR as Prognostic Biomarkers for Oropharyngeal Cancer Patients.
    Taberna M; Torres M; Alejo M; Mena M; Tous S; Marquez S; Pavón MA; León X; García J; Guix M; Hijano R; Bonfill T; Aguilà A; Lozano A; Mesía R; Alemany L; Bravo IG
    Front Oncol; 2018; 8():589. PubMed ID: 30619735
    [No Abstract]   [Full Text] [Related]  

  • 37. LRG1 and SDR16C5 protein expressions differ according to HPV status in oropharyngeal squamous cell carcinoma.
    Randén-Brady R; Carpén T; Hautala LC; Tolvanen T; Haglund C; Joenväärä S; Mattila P; Mäkitie A; Lehtonen S; Hagström J; Silén S
    Sci Rep; 2024 Jun; 14(1):14148. PubMed ID: 38898137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-expression of fibroblast growth factor receptor 3 with mutant p53, and its association with worse outcome in oropharyngeal squamous cell carcinoma.
    Nannapaneni S; Griffith CC; Magliocca KR; Chen W; Lyu X; Chen Z; Wang D; Wang X; Shin DM; Chen ZG; Saba NF
    PLoS One; 2021; 16(2):e0247498. PubMed ID: 33626078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial.
    Rischin D; Young RJ; Fisher R; Fox SB; Le QT; Peters LJ; Solomon B; Choi J; O'Sullivan B; Kenny LM; McArthur GA
    J Clin Oncol; 2010 Sep; 28(27):4142-8. PubMed ID: 20697079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elemental Zn and its Binding Protein Zinc-α2-Glycoprotein are Elevated in HPV-Positive Oropharyngeal Squamous Cell Carcinoma.
    Poropatich K; Paunesku T; Zander A; Wray B; Schipma M; Dalal P; Agulnik M; Chen S; Lai B; Antipova O; Maxey E; Brown K; Wanzer MB; Gursel D; Fan H; Rademaker A; Woloschak GE; Mittal BB
    Sci Rep; 2019 Nov; 9(1):16965. PubMed ID: 31740720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.